Thus, we identified substantial heterogeneity in all mouse models of SCLC, with NFIB promoting progression of central primary lesions to disseminated intrapulmonary metastasis and causing an increase in the number of bronchiolar lesions and with MYCL stimulating tumor initiation and progression at multiple locations along the pulmonary tree. This evidence concerns the gene MYCL and small cell lung carcinoma.